An integrated systems approach for incompletely penetrant onco-phenotypes
Kevin Janes, Ph.D.
Arizona Cancer and Evolution Center
Arizona Cancer and Evolution Center
Cancer Systems Biology Center of HoPE (Heterogeneity of Phenotypic Evolution)
City of Hope
Duarte, CA
Center for Cancer Systems Pharmacology (CCSP)
Harvard Medical School
Boston, MA
Center for Cancer Systems Therapeutics (CaST)
Columbia University
New York, NY
Combating Tumor Heterogeneity
Andrea Bild
Fred Adler
Adam Cohen
Complexity, Cooperation and Community in Cancer ([email protected])
University of California, Irvine
Irvine, CA
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Anderson
Robert Getenby
Scott Antonia
Embryonal brain tumor networks
Jill P. Mesirov
Ernest Fraenkel
Scott L. Pomeroy
Identification of personalized adaptive response mechanisms in breast cancer by information theory and proteomics
Forest White, PhD
Nataly Kravchenko-Balasha, PhD
Integrated mathematical and experimental analysis of immune system signaling in breast cancer
Dr. Lee
Dr. Rockne
Dr. Rodin
Measuring, Modeling and Controlling Heterogeneity (M2CH)
Oregon Health & Science University
University of California, Berkeley
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
Melissa Kemp, Ph.D.
Cristina Furdui, Ph.D.
Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression
Stanford University
Palo Alto, CA
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
Stephen T.C. Wong, PhD
Vivek Mittal, PhD
Multiscale Systems Biology Modeling to Exploit Tumor-stromal Metabolic Crosstalk in Colorectal Cancer
- Stacey Finley, Ph.D.
- Paul Macklin, Ph.D.
- Shannon Mumenthaler, Ph.D.
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
Matthew Lazzara, Ph.D.
Ben Stanger, M.D., Ph.D.
Babatunde Ogunnaike, Ph.D.
Todd Bauer, M.D.
Phenotype Transitions in Small Cell Lung Cancer
Vito Quaranta, M.D.
Carlos F. Lopez, Ph.D.
Precision lung cancer therapy design through multiplexed adapter measurement
Aaron Meyer
Eric Haura
Forest White
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Kristin R. Swanson
Leland S. Hu
J. Ross Mitchell
Nhan L. Tran
Quantitative and functional characterization of therapeutic resistance in cancer
Massachusetts Institute of Technology
Cambridge, MA
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer
H. Steven Wiley, Ph.D.
Herbert M Sauro Ph.D.
Wei-Jun Qian, Ph.D.
Tujin Shi, Ph.D.
Jin Xu, Ph.D.
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
Martha Bulyk
Juan Fuxman Bass
Marc Vidal
Single-cell characterization of tumor and microenvironment coevolution in Peripheral T-cell Lymphomas
Raul Rabadan, PhD
Teresa Palomero, PhD
Ioan Filip, PhD
Jose R. Cortes, PhD
Robert Albero, PhD
Systems analysis of aggressive prostate cancer pathology
James C Costello, Phd
Scott D Cramer, Phd
Systems Analysis of Epigenomic Architecture in Cancer Progression
University of Texas Health Science Center – San Antonio
Duke University
Systems Analysis of Phenotypic Switch in Control of Cancer Invasion
Yale University
New Haven, CT
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy
Douglas A Lauffenburger
Kevin M Haigis
Wilhelm Haas
Ken Lau
Kimmie Ng
The Cancer Cell Map Initiative
University of California, San Francisco
University of California, San Diego
The CSBC Research Center for Cancer Systems Immunology at MSKCC
Memorial Sloan Kettering Cancer Center
New York, NY
The CSBC U01 Research Project @ UPenn/Wistar Institute
Arjun Raj
Ravi Radhakrishnan
Junwei Shi
Abhyudai Singh
Ashani T. Weeraratna
The CSBC U54 Research Center @ Vanderbilt
Vanderbilt University
Stanford University